Biological effects of statins in systemic sclerosis: a systematic review and meta-analysis of 323 patients
DARU Journal of Pharmaceutical Sciences · 14.08.2026 · 34 (2)
DOI: 10.1007/s40199-026-00639-5 ↗Kurz gefasst
Metaanalyse in der Zeitschrift DARU Journal of Pharmaceutical Sciences, online erschienen am 14.08.2026. Verfasst von Mostafa A Khalifa und 16 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Cairo University, Cairo, Egypt. mostafakhalifa282@gmail.com. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Scleroderma, Systemic. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
INTRODUCTION: Systemic sclerosis (SSc) is driven by persistent inflammation and microvascular damage. Statins are hypothesized to offer vasculoprotective effects beyond lipid-lowering. We systematically evaluated the efficacy and safety of statins in SSc across biochemical, vascular, and patient-centred outcomes. METHODS: Following PRISMA guidelines, a systematic search of four electronic databases was conducted up to August 2025. Ten studies involving 323 patients were included. Pooled estimates were calculated using a random-effects model. Heterogeneity and sensitivity analyses were performed, and study quality was assessed using standardized appraisal tools. RESULTS: Statin therapy was associated with significant biochemical improvements. Compared with baseline or placebo, CRP decreased by an average of 0.70 mg/L, IL-6 by 5.56 pg/mL, and fibrinogen by 40 mg/dL. Endothelial markers showed similar reductions: 0.85 pg/mL for ET-1, 23.17 IU/dL for vWF, and 25 ng/mL for ICAM-1. Total cholesterol and LDL decreased by mean differences of 0.93 mmol/L and 0.76 mmol/L, respectively, while HDL showed no meaningful change. CONCLUSION: Statins improve inflammatory and endothelial pathways in systemic sclerosis, but these findings should be interpreted cautiously, as clinical benefits remain minimal. Randomized trials are required to further study statins' therapeutic role beyond biochemical modulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Cairo University, Cairo, Egypt. mostafakhalifa282@gmail.com.
- Khalifa International Medical Research Academy (KIMRA), Cairo, Egypt. mostafakhalifa282@gmail.com.
- College of Health Sciences, School of Nursing, Tennessee State University, Nashville, USA.
- Faculty of Medicine, Cairo University, Cairo, Egypt.
- Faculty of Medicine, Beirut Arab University Beirut, Beirut, Lebanon.
- Faculty of Medicine and Health Sciences, Omdurman Islamic University, Khartoum, Sudan.
Zitieren
APA
Khalifa, M. A., Alghzawi, H. M., Anan, S. S., Al Rifai, A., Anwar, A. A., Al-Saedi, H. A. R., Awady, E., Masood, I., Badr, M. E., Ismail, M., Muayaid, O., Ahmed, O. M., Bdarnh, O., Alkhatib, S., Elnagar, F., Hegazi, Y., & Jebril, M. (2026). Biological effects of statins in systemic sclerosis: a systematic review and meta-analysis of 323 patients. DARU Journal of Pharmaceutical Sciences, 34(2). https://doi.org/10.1007/s40199-026-00639-5
Vancouver
Khalifa MA, Alghzawi HM, Anan SS, Al Rifai A, Anwar AA, Al-Saedi HAR, et al. Biological effects of statins in systemic sclerosis: a systematic review and meta-analysis of 323 patients. DARU Journal of Pharmaceutical Sciences. 2026;34(2). doi:10.1007/s40199-026-00639-5
BibTeX
@article{Khalifa2026,
author = {Khalifa, Mostafa A and Alghzawi, Hamzah M and Anan, Shehabeldin S and Al Rifai, Ahmad and Anwar, Ayah A and Al-Saedi, Hayder Ali Raheem and Awady, Eman and Masood, Islam and Badr, Mohamed Elsayed and Ismail, Mohamed and Muayaid, Obada and Ahmed, Omar M and Bdarnh, Osama and Alkhatib, Sarah and Elnagar, Fares and Hegazi, Yasser and Jebril, Mohammad},
title = {Biological effects of statins in systemic sclerosis: a systematic review and meta-analysis of 323 patients},
journal = {DARU Journal of Pharmaceutical Sciences},
year = {2026},
volume = {34},
number = {2},
doi = {10.1007/s40199-026-00639-5}
}
EUVIMED